Gain A Valuable Insight Into India's Pharmaceutical Regulatory Environment For 2008 In This Comprehensive Report
DUBLIN, Ireland --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/9681f0/india_pharmaceutic) has announced the addition of the "India Pharmaceutical Regulatory Report 2008 (with appendix)" report to their offering.
The India Pharmaceutical Regulatory Report comprehensively covers all aspects of pharmaceutical regulations in India. It includes overviews of the laws and procedures on registration, manufacturing, distribution, price control, marketing, research and development, and intellectual property protection. It also includes an overview of the Indian pharmaceutical market and foreign involvement in the market up to 2008. How suited the country is to different kinds of market entry - such as manufacturing, sales, or research - is discussed in relation to the regulatory and market environment.
This report includes a 90-page appendix containing official forms, relevant excerpted regulations, and lists of pharmaceuticals with requirements such as special labeling, separate registration, or price controls.
Key Topics Covered:
- Indian Economy Overview
- Overview of Healthcare System
- Pharmaceutical Industry
- Regulatory Overview
- Drug Registration and Import
- Manufacturing
- Distribution
- Clinical Trials and R&D
- Intellectual Property Protection
- Drug Advertising
Companies Mentioned:
- Apollo Hospitals Group
- Wockhardt
- Fortis
- Max
- Escorts
- Dr. Reddy's Laboratories
- Ranbaxy
- Nicholas Piramal
- Cipla
- Betapharm
- AstraZeneca
- Bristol-Myers Squibb
- Merck
- Torrent Pharmaceuticals
- Novartis
- GlaxoSmithKline
- Karo Bio
- Zydus Cadila
For more information visit http://www.researchandmarkets.com/research/9681f0/india_pharmaceutic.
Copyright 2008 Business Wire All Rights Reserved.